These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88. Tengvall S; O'Hagan D; Harandi AM Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020 [TBL] [Abstract][Full Text] [Related]
84. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection. Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595 [TBL] [Abstract][Full Text] [Related]
85. Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis. Skinner GR; Woodman C; Hartley C; Buchan A; Fuller A; Wiblin C; Wilkins G; Melling J Dev Biol Stand; 1982; 52():333-44. PubMed ID: 6299842 [TBL] [Abstract][Full Text] [Related]
86. A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections. Frenkel L; Pineda E; Garratty E; Fall H; Dillon M; Bryson Y J Infect Dis; 1989 May; 159(5):845-50. PubMed ID: 2540245 [TBL] [Abstract][Full Text] [Related]
88. Serum antibodies to herpes simplex virus type 1 during active oral herpes infection. Ratner JJ; Smith KO Infect Immun; 1980 Jan; 27(1):113-7. PubMed ID: 6244224 [TBL] [Abstract][Full Text] [Related]
89. Recent progress in herpes simplex virus immunobiology and vaccine research. Koelle DM; Corey L Clin Microbiol Rev; 2003 Jan; 16(1):96-113. PubMed ID: 12525427 [TBL] [Abstract][Full Text] [Related]
90. Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine. Ashley R; Mertz G; Clark H; Schick M; Salter D; Corey L J Virol; 1985 Nov; 56(2):475-81. PubMed ID: 2997470 [TBL] [Abstract][Full Text] [Related]
91. Animal studies on the efficacy of vaccination against recurrent herpes. Scriba M Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061 [TBL] [Abstract][Full Text] [Related]
92. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine. Scriba M Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688 [TBL] [Abstract][Full Text] [Related]
93. The relative infrequency and low levels of neutralising and immunoprecipitating antibody to herpes simplex viruses types 1 and 2 in patients with a history of recurrent herpes genitalis. Woodman CB; Stocker D; Sugrue D; Desberbasques M; Hartley CE; Fuller A; Buchan A; Skinner GR Med Microbiol Immunol; 1983; 171(4):243-50. PubMed ID: 6304481 [TBL] [Abstract][Full Text] [Related]
94. Unusual serologic response to two patients to an early antigen of herpes simplex virus type 2. Arsenakis M; May JT Sex Transm Dis; 1982; 9(3):143-5. PubMed ID: 6293106 [TBL] [Abstract][Full Text] [Related]
95. The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice. Schneweis KE; Gruber J; Hilfenhaus J; Möslein A; Kayser M; Wolff MH Med Microbiol Immunol; 1981; 169(4):269-79. PubMed ID: 6268958 [TBL] [Abstract][Full Text] [Related]